Literature DB >> 21810418

Food-derived oligosaccharides exhibit pharmaceutical properties.

Anneke Rijnierse1, Prescilla V Jeurink, Betty C A M van Esch, Johan Garssen, Léon M J Knippels.   

Abstract

Breast feeding is considered as the best nutrition for growth and development of an infant. Human milk consists of a unique combination of nutritional components each with different characteristics. Oligosaccharides or non-digestible carbohydrates as one of these components, are generally accepted to have a beneficial effect by selectively stimulating the growth and/or activity of one or a limited number of bacterial species. Recently more evidence is rising for direct effects of oligosaccharides on the immune system. Oligosaccharides often used as dietary supplements for their beneficial effects on the host and its immune system, are derived from nutritional sources. In this review we aim to summarize the pharmaceutical properties of these food-borne oligosaccharides early in life.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21810418     DOI： 10.1016/j.ejphar.2011.07.009

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN： 0014-2999            Impact factor:   4.432


  10 in total

Review 1.  Human milk oligosaccharides: every baby needs a sugar mama.

Authors:  Lars Bode
Journal:  Glycobiology       Date:  2012-04-18       Impact factor: 4.313

2.  Safety of 3'-sialyllactose (3'-SL) sodium salt produced by derivative strains of Escherichia coli BL21 (DE3) as a Novel Food pursuant to Regulation (EU) 2015/2283.

Authors:  Dominique Turck; Torsten Bohn; Jacqueline Castenmiller; Stefaan De Henauw; Karen Ildico Hirsch-Ernst; Alexandre Maciuk; Inge Mangelsdorf; Harry J McArdle; Androniki Naska; Carmen Pelaez; Kristina Pentieva; Alfonso Siani; Frank Thies; Sophia Tsabouri; Marco Vinceti; Francesco Cubadda; Thomas Frenzel; Marina Heinonen; Rosangela Marchelli; Monika Neuhäuser-Berthold; Morten Poulsen; Miguel Prieto Maradona; Josef Rudolf Schlatter; Henk van Loveren; Paolo Colombo; Estefanía Noriega Fernández; Helle Katrine Knutsen
Journal:  EFSA J       Date:  2022-05-25

3.  Safety of 3-fucosyllactose (3-FL) produced by a derivative strain of Escherichia coli BL21 (DE3) as a Novel Food pursuant to Regulation (EU) 2015/2283.

Authors:  Dominique Turck; Torsten Bohn; Jacqueline Castenmiller; Stefaan De Henauw; Karen Ildico Hirsch-Ernst; Alexandre Maciuk; Inge Mangelsdorf; Harry J McArdle; Androniki Naska; Carmen Pelaez; Kristina Pentieva; Alfonso Siani; Frank Thies; Sophia Tsabouri; Marco Vinceti; Francesco Cubadda; Thomas Frenzel; Marina Heinonen; Rosangela Marchelli; Monika Neuhäuser-Berthold; Morten Poulsen; Miguel Prieto Maradona; Josef Rudolf Schlatter; Henk van Loveren; Paolo Colombo; Estefanía Noriega Fernández; Helle Katrine Knutsen
Journal:  EFSA J       Date:  2022-05-25

Review 4.  Profiles of human milk oligosaccharides and production of some human milk oligosaccharides in transgenic animals.

Authors:  Pedro Antonio Prieto
Journal:  Adv Nutr       Date:  2012-05-01       Impact factor: 8.701

Review 5.  Bioactive Compounds in Infant Formula and Their Effects on Infant Nutrition and Health: A Systematic Literature Review.

Authors:  Cristine Couto Almeida; Bianca Figueiredo Mendonça Pereira; Katia Christina Leandro; Marion Pereira Costa; Bernardete Ferraz Spisso; Carlos Adam Conte-Junior
Journal:  Int J Food Sci       Date:  2021-05-14

6.  In Vitro Evidence for Immune-Modulatory Properties of Non-Digestible Oligosaccharides: Direct Effect on Human Monocyte Derived Dendritic Cells.

Authors:  Sarah Lehmann; Julia Hiller; Jeroen van Bergenhenegouwen; Leon M J Knippels; Johan Garssen; Claudia Traidl-Hoffmann
Journal:  PLoS One       Date:  2015-07-06       Impact factor: 3.240

7.  Effects of orally administered galacto-oligosaccharides on immunological parameters in foals: a pilot study.

Authors:  Johannes Cornelis Vendrig; Luc Edgar Coffeng; Johanna Fink-Gremmels
Journal:  BMC Vet Res       Date:  2014-11-19       Impact factor: 2.741

8.  Improved Efficacy of Oral Immunotherapy Using Non-Digestible Oligosaccharides in a Murine Cow's Milk Allergy Model: A Potential Role for Foxp3+ Regulatory T Cells.

Authors:  Marlotte M Vonk; Mara A P Diks; Laura Wagenaar; Joost J Smit; Raymond H H Pieters; Johan Garssen; Betty C A M van Esch; Léon M J Knippels
Journal:  Front Immunol       Date:  2017-09-29       Impact factor: 7.561

9.  Safety of 3-FL (3-Fucosyllactose) as a novel food pursuant to Regulation (EU) 2015/2283.

Authors:  Dominique Turck; Jacqueline Castenmiller; Stefaan De Henauw; Karen Ildico Hirsch-Ernst; John Kearney; Alexandre Maciuk; Inge Mangelsdorf; Harry J McArdle; Androniki Naska; Carmen Pelaez; Kristina Pentieva; Alfonso Siani; Frank Thies; Sophia Tsabouri; Marco Vinceti; Francesco Cubadda; Thomas Frenzel; Marina Heinonen; Rosangela Marchelli; Monika Neuhäuser-Berthold; Morten Poulsen; Miguel Prieto Maradona; Josef Rudolf Schlatter; Henk van Loveren; Paolo Colombo; Helle Katrine Knutsen
Journal:  EFSA J       Date:  2021-06-30

10.  In vitro evaluation of defined oligosaccharide fractions in an equine model of inflammation.

Authors:  Johannes Cornelis Vendrig; Luc Edgar Coffeng; Johanna Fink-Gremmels
Journal:  BMC Vet Res       Date:  2013-07-22       Impact factor: 2.741
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.